Literature DB >> 24372652

Inflammatory peeling skin syndrome caused by homozygous genomic deletion in the PSORS1 region encompassing the CDSN gene.

Akemi Ishida-Yamamoto1, Laetitia Furio, Satomi Igawa, Masaru Honma, Elodie Tron, Valerie Malan, Masamoto Murakami, Alain Hovnanian.   

Abstract

Peeling skin syndrome (PSS) type B is a rare recessive genodermatosis characterized by lifelong widespread, reddish peeling of the skin with pruritus. The disease is caused by small-scale mutations in the Corneodesmosin gene (CDSN) leading to premature termination codons. We report for the first time a Japanese case resulting from complete deletion of CDSN. Corneodesmosin was undetectable in the epidermis, and CDSN was unamplifiable by PCR. QMPSF analysis demonstrated deletion of CDSN exons inherited from each parent. Deletion mapping using microsatellite haplotyping, CGH array and PCR analysis established that the genomic deletion spanned 49-72 kb between HCG22 and TCF19, removing CDSN as well as five other genes within the psoriasis susceptibility region 1 (PSORS1) on 6p21.33. This observation widens the spectrum of molecular defects underlying PSS type B and shows that loss of these five genes from the PSORS1 region does not result in an additional cutaneous phenotype.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  PSORS1; corneodesmosin; peeling skin syndrome

Mesh:

Substances:

Year:  2014        PMID: 24372652     DOI: 10.1111/exd.12292

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  2 in total

1.  A novel pathogenic variant in the corneodesmosin gene causing generalized inflammatory peeling skin syndrome with marked eosinophilia and trichorrhexis invaginata.

Authors:  Helen Gordon; Patrick Yap; Kuang-Chih Hsiao; Michael Watson; Diana Purvis
Journal:  Pediatr Dermatol       Date:  2022-02-17       Impact factor: 1.997

2.  Corneodesmosin as a potential target of oral squamous cell carcinoma.

Authors:  Yong-Bin Di; Yang Bao; Jie Guo; Wei Liu; Su-Xin Zhang; Guan-Hua Zhang; Tian-Ke Li
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.